Patents by Inventor Haris Durutlic

Haris Durutlic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the synthesis of progesterone receptor modulators
    Patent number: 7754895
    Abstract: Processes for preparing oxindoles, which can be utilized in the preparation of a variety of useful compounds, and methods for minimizing or preventing N-alkylation of amide containing compounds, including oxindoles, are provided.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: July 13, 2010
    Assignee: Wyeth LLC
    Inventors: Yanzhong Wu, Bogdan Kazimierz Wilk, Zhixian Ding, Xinxu Shi, Charles Chao Wu, Panolil Raveendranath, Haris Durutlic
  • Thieno [ 3,2-b] pyridine-6-carbonitriles and thieno [2,3-b] pyridine-5-carbonitriles as protein kinase inhibitors
    Publication number: 20080070913
    Abstract: This invention provides compounds of Formula (1a)-(1f), II wherein: X, m, n, q, R1, R2, R3, R4, R5, R6, R7, R8, R9, Y, Q, Z, Z?, Z??, Z? and J are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, myocardial infarction, neuropathic pain, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection and process for producing said compounds.
    Type: Application
    Filed: September 24, 2007
    Publication date: March 20, 2008
    Inventors: Diane Boschelli, Nan Zhang, Ana Barrios Sosa, Haris Durutlic, Biqi Wu
  • Processes for synthesizing piperazine-piperidine compounds
    Publication number: 20080058523
    Abstract: The present invention relates to processes for synthesizing piperazine-piperidine compounds, and compounds useful as 5-HT1A binding agents, particularly as 5-HT1A receptor antagonists and agonists. The processes also allow for safer and environmentally tolerant production of these useful compounds.
    Type: Application
    Filed: June 7, 2007
    Publication date: March 6, 2008
    Inventors: Weiguo Liu, Vladimir Dragan, Henry Strong, Yanzhong Wu, Zhixin Wen, Jessica Liang, Haris Durutlic, Karen Sutherland, Anthony Pilcher
  • Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
    Patent number: 7276519
    Abstract: This invention provides compounds of Formula (1a)–(1f), II wherein: X, m, n, q, R1, R2, R3, R4, R5, R6, R7, R8, R9, Y, Q, Z, Z?, Z??, Z? and J are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, myocardial infarction, neuropathic pain, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection and process for producing said compounds.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: October 2, 2007
    Assignee: Wyeth
    Inventors: Diane Harris Boschelli, Nan Zhang, Ana Carolina Barrios Sosa, Haris Durutlic, Biqi Wu
  • Process for preparing beta-lactamase inhibitors
    Publication number: 20070149499
    Abstract: The present invention relates to processes for preparing ?-alkylidene penem derivatives that can be important as broad spectrum ?-lactamase inhibitors and anti-bacterial agents.
    Type: Application
    Filed: August 22, 2006
    Publication date: June 28, 2007
    Applicant: Wyeth
    Inventors: Ronald Michalak, Rocco Galante, David Blum, Julianne Blum, Lisa Routel, Haris Durutlic, Charles Guinosso, John Considine, Kenneth Kremer
  • Process for the synthesis of progesterone receptor modulators
    Publication number: 20070027327
    Abstract: Processes for preparing oxindoles, which can be utilized in the preparation of a variety of useful compounds, and methods for minimizing or preventing N-alkylation of amide containing compounds, including oxindoles, are provided.
    Type: Application
    Filed: July 27, 2006
    Publication date: February 1, 2007
    Applicant: Wyeth
    Inventors: Yanzhong Wu, Bogdan Wilk, Zhixian Ding, Xinxu Shi, Charles Wu, Panolil Raveendranath, Haris Durutlic
  • Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
    Patent number: 6987116
    Abstract: This invention provides compounds of Formula (1a)-(1f) wherein: X, R1, and R2 are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection and process for producing said compounds.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: January 17, 2006
    Assignee: Wyeth
    Inventors: Diane Harris Boschelli, Nan Zhang, Ana Carolina Barrios Sosa, Haris Durutlic, Biqi Wu
  • Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
    Publication number: 20040242883
    Abstract: This invention provides compounds of Formula (1a)-(1f), II 1
    Type: Application
    Filed: May 14, 2004
    Publication date: December 2, 2004
    Applicant: Wyeth
    Inventors: Diane Harris Boschelli, Nan Zhang, Ana Carolina Barrios Sosa, Haris Durutlic, Biqi Wu
  • Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
    Publication number: 20040138251
    Abstract: This invention provides compounds of Formula (Ia)-(If) 1
    Type: Application
    Filed: November 21, 2003
    Publication date: July 15, 2004
    Applicant: Wyeth
    Inventors: Diane Harris Boschelli, Nan Zhang, Ana Carolina Barrios Sosa, Haris Durutlic, Biqi Wu